{"cdcTestId":"2013-0096","testcaseName":"# 3 Pediarix at 14 wks-4 days.","vaccineGroup":"DTAP","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-17T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-23T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2023-10-17T00:00:00","recommendedDate":"2023-10-17T00:00:00","pastDueDate":"2024-03-15T00:00:00"},"doses":[{"dateAdministered":"2022-08-26T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-23T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PEDIARIX","cvx":"110","mvx":"SKB","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-08-17T14:28:48.525","generalDescription":"This test case describes when a child is administered, Pediarix as the third dose of DTaP vaccine, at age 14 weeks - 4 days that the dose is valid.  Another dose should be forecast.","changedInVersion":"3.3","reasonForChange":"Updated per the 2017 General Best Practice Guidelines which moved the Minimum and Recommended Age to 15 months"}